NEŞE ÇÖLÇİMEN, MURAT ÇETİN RAĞBETLİ, Mikail KARA, OKAN ARIHAN, Veysel AKYOL

Investigation of the effects of diclofenac sodium in rat ovary on the number of preantral follicles by stereological methods in prenatal period

For healthy future generations pregnancy is a period in which maximum amount of attention should be given. In this period, choice, duration and dosage of medication as well as the changing physiology of the mother should be taken into account. Non-steroidal anti-inflammatory drugs (NSAIDs) are a group of drugs that have analgesic, anti-pyretic and antiinflammatory effects. This group of drugs can be used in the treatment of the ongoing rheumatic diseases or which occur during the pregnancy period and the complications that occur due to pregnancy. We aimed to show how it affects the number of ovarium preantral follicles of newborn fetus on rats by using Diclofenac Sodium which belongs to this drug family group. Diclofenac Sodium (1 mg / kg, IM) was injected for 15 days from the 5th day of pregnancy to pregnant rats in Diclofenac Sodium group and saline (1 ml / kg, IM) was injected to the pregnant rats of the sham group at the same time period. In the 4th week after birth, ovarian tissue preparates of rat pups were stained with hematoxylin-eosin and ovarian total tissue volumes and preantral follicle counts were evaluated under light microscope. There was no statistically significant difference between groups for ovarium total tissue volumes and preantral follicle numbers (p>0.05). Lowest value of follicular intensity was observed in Diclofenac sodium group among study groups however no statistically important difference was found (p>0.05). Results obtained in our study may be related with administration of drug in not a high dosage (1mg/kg). Further studies may be performed with higher doses.

___

1. İskit AB. Drug selection in pregnant patients. Continuing Education Journal 2007; 16: 15-17.

2. Satılmış M, Bilgili A. Nonsteroidal antiinflammatory drug new use options. Rewiew Article. Journal of Faculy Veterinary Medicine, Erciyes University 2013; 10: 63-71.

3. Pınar N. Drug expenditures in our country / Review, Journal of Turgut Ozal Medical Center 2012; 19: 59-65.

4. Gökalp O, Mollaoğlu H. Inappropriate drug use. Süleyman Demirel University Faculty of Medicine Journal 2003; 10: 17-20.

5. Lucas S. Medication use in the treatment of migraine during pregnancy and lactation. Curr Pain Headache Rep 2009; 13: 392-398.

6. Gökçimen A, Malas MA. Review of literature on nonsteroidal anti-inflammatory drugs in pregnancy toxicities. Süleyman Demirel University Faculty of Medicine Journal 2003; 10: 50-52.

7. Odacı E, Korkmaz A, Ayas B, Rağbetli MÇ, Çiftçi N. Effect of Prenatal Diclofenac Sodium exposure onthe rat artıcular Cartılage of the rat in postnatal period. Turkey Clinics Journal of Medical Sciences 2001; 21: 278-281.

8. Güven D, Altunkaynak BZ, Ayranci E, et al. Stereological and histopathological evaluation of ovary and uterine horns of female rats prenatally exposed to diclofenac sodium. Journal of Obstetrics & Gynaecology 2013; 33: 258-263.

9. Gundersen HJ, Jensen EB. The efficiency of systematic sampling in stereology and its prediction. J Microsc 1987; 147: 229-263.

10. Gundersen HJ, Bendtsen TF, Korbo L, et al. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 1988; 96: 379-394.

11. Howard C.V. Reed M.G. Unbiased stereology, threedimensionel measurements in microscopy (pp. 39- 68). Oxford: BIOS Scientific Publishers 1998.

12. Hasçelik Z. Nonsteroidal antiinflammatory drugs. Continuing Education Journal 2001; 10: 1.

13. Duman EN. The role of NSAIDs in the treatment of chronic pain. Clinical Development Journal 2007; 20: 145-149.

14. Özbudak H, Ünal AZ, Sabuncuoğlu S. Evaluation of the use of non-steroidal antiinflammatory drugs in pregnancy. Marmara Pharmaceutical Journal 2016; 20: 64-71. DOI:10.1291/mpj.20162059818.

15. Weissmann G. Aspirin. Sci Am 1991; 264: 84-90.

16. Ommaty R. Vademecum 2003. Modern drug guide. 23. Edition. 492-1192. Feryal printing press. Ankara, 2003.

17. Kökçü A, Üstün C, Çokşenim Ş, Balat Ö. The effect of Diclofenac Sodium administered to the pregnant rat on fetal number and pregnancy duration. T Klin Jinekol Obst 1992; 2: 295-229.

18. Ostensen M. Treatment of inflammatory rheumatic disorders in pregnancy: what are the safest treatment options? Drug Saf 1998; 19: 389-410.

19. Ostensen M. Nonsteroidal anti-inflammatory drugs during pregnancy. Scand J. Rheumatol Suppl 1998; 107: 128-132.

20. Chan LY, Chiu PY, Siu SS, Lau TK. A study of diclofenac-induced teratogenicity during organogenesis using a whole rat embryo culture model. Hum Reprod 2001; 16: 2390-2393.

21. Carp HJ, Fein A, Nebel L. Effect of diclofenac on implantation and embryonic development in the rat. Eur J Obstet Gynecol Reprod Biol 1988; 28: 273- 277.

22. Needs CJ, Brooks PM. Antirheumatic medication in pregnancy. Br J Rheumatol 1985; 24: 382-390.

23. Russell JG. Antirheumatic medication in pregnancy. Br J Rheumatol 1986; 25: 229.

24. Üstün C, Kökçü A, Çokşemin Ş, Kandemir B. Effect of prostaglandin synthesis inhibitor Diclofenac Sodium on ovarian folliculogenesis in rats. T Klin Jinekol Obst 1993; 3: 70-72.